GPHARMA
Board
1 director, since incorporationDirector (not named in the articles)
appointed by deed of 12-10-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 18-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 11. Pouvoirs de l’organe d’administration S’il n’y a qu’un seul administrateur, la totalité des pouvoirs d’administration lui est…”deed of 12-10-2023
Mandates through the years
1 name, the dashed line is todayMARCOTTY Géraldine Christine Pascale Marie
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- MARCOTTY Géraldine Christine Pascale Marie
- Director (not named in the articles), appointed by deed of 12-10-2023, still in office
Control
Founders
MARCOTTY Géraldine Christine Pascale Marie, MARCOTTY Louis Philippe Marie Oscar Ghislain
This company
GPHARMA
Equity €223,496
Profit €52,848 in 2025
Capital
- Contribution
- €100,000
- Shares
- 1,000
- Contribution per share
- €100
- Equity per share
- €223 in 2025
- Source
- deed of 12-10-2023
Articles of association
deed of 12-10-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of May at 18:00
Shareholders
At incorporation
deed of 12-10-2023 ↗
- MARCOTTY Géraldine Christine Pascale Marie 900 shares (90%) · €90,000
- MARCOTTY Louis Philippe Marie Oscar Ghislain 100 shares (10%) · €10,000